Clinical significance of Interleukin 17 receptor E in diabetic nephropathy-Reference-Cited by-同舟云学术

Clinical significance of Interleukin 17 receptor E in diabetic nephropathy

Published:2023-07 Issue: Volume:120 Page:110324
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Wang Jingjing,Wang Xian,Wang Meixi,Wang Jinni,Wu Yonggui^ORCID,Qi Xiangming

Funder

Natural Science Foundation of Anhui Province

Anhui Medical University

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference41 articles.

1. A more tubulocentric view of diabetic kidney disease;Zeni;J. Nephrol.,2017

2. Identification of hub genes and potential ceRNA networks of diabetic nephropathy by weighted gene co-expression network analysis;Li;Front. Genet.,2021

3. A network pharmacology-based strategy for unveiling the mechanisms of tripterygium wilfordii hook F against diabetic kidney disease;Wang;J. Diabetes Res.,2020

4. The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseases;Berry;Int. Immunopharmacol.,2022

5. IL-17A in diabetic kidney disease: protection or damage;Tan;Int Immunopharmacol.,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. rs-TAC PDC, a peptide drug-conjugate, for targeted delivery of tacrolimus and sericin alleviates podocyte injury in diabetic nephropathy;Nano Today;2024-08

2. Elevated ALOX12 in renal tissue predicts progression in diabetic kidney disease;Renal Failure;2024-02-12

3. Correlation between gut microbiome and cognitive impairment in patients undergoing peritoneal dialysis;BMC Nephrology;2023-12-05